Compound information
- Natural Products
- ZC744620
- Molecular Formula
- C23H29N5O5
- Molecular Weight
- 455.216869028 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-[[(2R)-2-(benzyloxycarbonylamino)-3-phenyl-propanoyl]amino]-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C23H29N5O5/c24-22(25)26-13-7-12-18(21(30)31)27-20(29)19(14-16-8-3-1-4-9-16)28-23(32)33-15-17-10-5-2-6-11-17/h1-6,8-11,18-19H,7,12-15H2,(H,27,29)(H,28,32)(H,30,31)(H4,24,25,26)/t18-,19+/m0/s1
- InChI Key
- XHGIWCXAACQYGK-RBUKOAKNSA-N
- SMILES
- N=C(N)NCCC[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC000008761994
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 33 | Ring Count | 2 |
Heteroatom Count | 10 | Rotatable Bond Count | 12 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 6 |
Topological Polar Surface Area | 166.63 Å2 | LogP | 1.153 |
LogS | -3.091 | LogD | 0.553 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.863 |
HIA | 0.002 | F20 % | 0.18 |
F30 % | 0.0 | Caco-2 | -6.576 |
MDCK | -5.784 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.949 | PPB | 52.693 |
VD | 0.547 | Fu | 0.549 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.717 |
CYP2A6 substrate | 0.326 | CYP2B6 substrate | 0.37 |
CYP2C19 inhibitor | 0.146 | CYP2C19 substrate | 0.68 |
CYP2C8 substrate | 0.658 | CYP2C9 inhibitor | 0.117 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.146 |
CYP2D6 substrate | 0.474 | CYP2E1 substrate | 0.359 |
CYP3A4 inhibitor | 0.028 | CYP3A4 substrate | 0.954 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.788 | CL | 2.789 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.352 | Hepatotoxicity | 0.153 |
Mutagenicity | 0.029 | Rat Oral Acute Toxicity | 0.144 |
FDAMDD | 0.221 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.001 | Eye Corrosion | 0.004 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.115 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.455 | IGC50 | 2.318 |
LC50FM | 3.112 | LC50DM | 2.579 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.393 | NR-AR-LBD | 0.352 |
NR-AhR | 0.005 | NR-Aromatase | 0.023 |
NR-ER | 0.34 | NR-ER-LBD | 0.353 |
NR-PPAR-gamma | 0.422 | SR-ARE | 0.125 |
SR-ATAD5 | 0.34 | SR-HSE | 0.068 |
SR-MMP | 0.01 | SR-p53 | 0.037 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.